92 related articles for article (PubMed ID: 1446671)
1. Synthetic peptides as antagonists of the anaphylatoxin C3a.
Kretzschmar T; Pohl M; Casaretto M; Przewosny M; Bautsch W; Klos A; Saunders D; Köhl J
Eur J Biochem; 1992 Nov; 210(1):185-91. PubMed ID: 1446671
[TBL] [Abstract][Full Text] [Related]
2. Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.
Kola A; Klos A; Bautsch W; Kretzschmar T; Köhl J
Clin Exp Immunol; 1992 May; 88(2):368-72. PubMed ID: 1572104
[TBL] [Abstract][Full Text] [Related]
3. Cyclic disulfide analogues of the complement component C3a. Synthesis and conformational investigations.
Pohl M; Ambrosius D; Grötzinger J; Kretzschmar T; Saunders D; Wollmer A; Brandenburg D; Bitter-Suermann D; Höcker H
Int J Pept Protein Res; 1993 Apr; 41(4):362-75. PubMed ID: 8496018
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of the C3a active site using short synthetic C3a analogues.
Köhl J; Casaretto M; Gier M; Karwath G; Gietz C; Bautsch W; Saunders D; Bitter-Suermann D
Eur J Immunol; 1990 Jul; 20(7):1463-8. PubMed ID: 2387312
[TBL] [Abstract][Full Text] [Related]
5. The active site of human C4a anaphylatoxin.
Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
[TBL] [Abstract][Full Text] [Related]
6. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of a specific C3a receptor on guinea pig platelets.
Fukuoka Y; Hugli TE
J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
[TBL] [Abstract][Full Text] [Related]
8. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
[TBL] [Abstract][Full Text] [Related]
9. Designing synthetic superagonists of C3a anaphylatoxin.
Ember JA; Johansen NL; Hugli TE
Biochemistry; 1991 Apr; 30(15):3603-12. PubMed ID: 2015217
[TBL] [Abstract][Full Text] [Related]
10. Synthetic C3a analogs as specific inhibitors of C3a activity.
Meuer S; Hadding U; Andreatta R; Bitter-Suermann D
Immunopharmacology; 1981 Sep; 3(3):275-80. PubMed ID: 6975766
[TBL] [Abstract][Full Text] [Related]
11. Human anaphylatoxin C4a is a potent agonist of the guinea pig but not the human C3a receptor.
Lienenklaus S; Ames RS; Tornetta MA; Sarau HM; Foley JJ; Crass T; Sohns B; Raffetseder U; Grove M; Hölzer A; Klos A; Köhl J; Bautsch W
J Immunol; 1998 Sep; 161(5):2089-93. PubMed ID: 9725198
[TBL] [Abstract][Full Text] [Related]
12. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
Zanker B; Rasokat H; Hadding U; Bitter-Suermann D
Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
Fukuoka Y; Ember JA; Hugli TE
J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
[TBL] [Abstract][Full Text] [Related]
14. Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements.
Gerardy-Schahn R; Ambrosius D; Casaretto M; Grötzinger J; Saunders D; Wollmer A; Brandenburg D; Bitter-Suermann D
Biochem J; 1988 Oct; 255(1):209-16. PubMed ID: 3264156
[TBL] [Abstract][Full Text] [Related]
15. Characterization of synthetic C3a analog peptides on human eosinophils in comparison to the native complement component C3a.
Petering H; Köhl J; Weyergraf A; Dulkys Y; Kimmig D; Smolarski R; Kapp A; Elsner J
J Immunol; 2000 Apr; 164(7):3783-9. PubMed ID: 10725738
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.
Becker S; Hadding U; Schorlemmer HU; Bitter-Suermann D
Scand J Immunol; 1978; 8(6):551-5. PubMed ID: 734357
[TBL] [Abstract][Full Text] [Related]
17. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a.
Huey R; Erickson BW; Bloor CM; Hugli TE
Immunopharmacology; 1984 Aug; 8(1):37-45. PubMed ID: 6333413
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin.
Becker S; Meuer S; Hadding U; Bitter-Suermann D
Scand J Immunol; 1978; 7(2):173-80. PubMed ID: 653315
[TBL] [Abstract][Full Text] [Related]
19. Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.
Hartung HP; Bitter-Suermann D; Hadding U
J Immunol; 1983 Mar; 130(3):1345-9. PubMed ID: 6600482
[TBL] [Abstract][Full Text] [Related]
20. Anaphylatoxin C3a induces rapid protein phosphorylation in guinea pig platelets.
Fukuoka Y; Tachibana T; Yasui A
Immunopharmacology; 1994; 28(2):95-104. PubMed ID: 8002292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
